where a spacer represents Y represents N; R1 and R2 together with nitrogen atom whereto attached form a 5-6-members heterocyclic ring system which is optionally substituted by 1-3 (C1-C5)alkyl groups; n is equal to 2-4; R represents 0-2 groups selected from halogen atom, (C1-C6)alkyl, (C1-C6)alkoxy groups; R4 and R5 are independently selected from H, (C1-C5)alkyl, (C1-C8)alkoxy groups, halogen atom; R6 represents H, CONR7R8, -(CH2)x-O-R9, (C1-C4)alkyl group, COOC2H5, cyclopropyl; x is equal to 1-4; R7 and R8 independently represent hydrogen, (C1-C5)alkyl group, (C3-C7)-cycloalkyl group, -CH2-cyclohexyl, or R7 and R8 together with nitrogen atom whereto attached form a 5-6-members heterocyclic ring system with 0-1 additional heteroatom selected from O; R9 represents hydrogen, (C1-C5)alkyl, (C3-C7)cycloalkyl group; and its pharmaceutically acceptable salt, and its individual stereoisomers.;EFFECT: compounds inhibit histamine H3-receptor that allows to use them for preparing pharmaceutical compositions.;6 cl, 10 dwg, 1 tbl, 44 ex"/> INDOLE DERIVATIVES AS HISTAMINE H<Sub>3</Sub>-RECEPTOR INHIBITORS FOR TREATING COGNITIVE DISORDERS AND SLEEP DISTURBANCES, OBESITY AND OTHER DISORDERS OF CENTRAL NERVOUS SYSTEM
首页> 外国专利> INDOLE DERIVATIVES AS HISTAMINE H3-RECEPTOR INHIBITORS FOR TREATING COGNITIVE DISORDERS AND SLEEP DISTURBANCES, OBESITY AND OTHER DISORDERS OF CENTRAL NERVOUS SYSTEM

INDOLE DERIVATIVES AS HISTAMINE H3-RECEPTOR INHIBITORS FOR TREATING COGNITIVE DISORDERS AND SLEEP DISTURBANCES, OBESITY AND OTHER DISORDERS OF CENTRAL NERVOUS SYSTEM

机译:吲哚衍生物作为组胺H 3 受体抑制剂用于治疗中枢神经系统的认知障碍和睡眠障碍,肥胖症和其他疾病

摘要

FIELD: medicine, pharmaceutics.;SUBSTANCE: invention refers to compounds of formula: where a spacer represents Y represents N; R1 and R2 together with nitrogen atom whereto attached form a 5-6-members heterocyclic ring system which is optionally substituted by 1-3 (C1-C5)alkyl groups; n is equal to 2-4; R represents 0-2 groups selected from halogen atom, (C1-C6)alkyl, (C1-C6)alkoxy groups; R4 and R5 are independently selected from H, (C1-C5)alkyl, (C1-C8)alkoxy groups, halogen atom; R6 represents H, CONR7R8, -(CH2)x-O-R9, (C1-C4)alkyl group, COOC2H5, cyclopropyl; x is equal to 1-4; R7 and R8 independently represent hydrogen, (C1-C5)alkyl group, (C3-C7)-cycloalkyl group, -CH2-cyclohexyl, or R7 and R8 together with nitrogen atom whereto attached form a 5-6-members heterocyclic ring system with 0-1 additional heteroatom selected from O; R9 represents hydrogen, (C1-C5)alkyl, (C3-C7)cycloalkyl group; and its pharmaceutically acceptable salt, and its individual stereoisomers.;EFFECT: compounds inhibit histamine H3-receptor that allows to use them for preparing pharmaceutical compositions.;6 cl, 10 dwg, 1 tbl, 44 ex
机译:技术领域:药物,药剂学。实质:本发明是指具有以下化学式的化合物:表示 <图像文件=” 00000068.GIF“ he =” 46“ imgContent =” undefined“ imgFormat =” GIF“ wi =” 25“ /> Y代表N; R 1 和R 2 与连接的氮原子一起形成5-6元杂环系统,可选地被1-3(C 1 < / Sub> -C 5 )烷基; n等于2-4; R代表选自卤素原子,(C 1 -C 6 )烷基,(C 1 -C 6的0-2个基团)烷氧基; R 4 和R 5 独立地选自H,(C 1 -C 5 )烷基, 1 -C 8 )烷氧基,卤原子; R 6 代表H,CONR 7 R 8 ,-(CH 2 x -OR 9 ,(C 1 -C 4 )烷基,COOC 2 H 5 ,环丙基; x等于1-4; R 7 和R 8 独立地代表氢,(C 1 -C 5 )烷基,(C < Sub> 3 -C 7 )-环烷基,-CH 2 -环己基或R 7 和R 8 与氮原子连接形成5-6元杂环系统,并带有0-1个额外的选自O的杂原子; R 9 代表氢,(C 1 -C 5 )烷基,(C 3 -C 7 )环烷基;效果:化合物抑制组胺H 3 -受体,可用于制备药物组合物。; 6 cl,10 dwg,1 tbl,44 ex

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号